Apples WWDC AI Showcase Could Determine Stocks Next Move Ohio Woman Discovers ExBoyfriend Secretly Charged Nearly 17000 to Her Credit Cards Ramsey Show Advises Treating It as Fraud SP 500 Edges Higher Led by Healthcare and Tech Communication Services Lags Hajj 2026 Over 15 Million Foreign Pilgrims Arrive in Saudi Arabia Amid Regional Tensions NARCL Retains Guarantees of Jaypee ExPromoters to Boost Dues Recovery Toronto Blue Jays Legend Passes at Age Age Unknown from Source GM Q1 2026 Earnings Earnings Per Share Smashes Estimates Driving Optimism Pineapple Financial Inc PAPL Q3 2025 Earnings SmallerThanExpected Loss Highlights Cost Discipline Amid Revenue Uncertainty ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline CACI Q1 2026 Earnings EPS Beat Drives Positive Early Trading MACOM Technology Solutions MTSI Shares Decline 258 as Tech Sector Headwinds Persist Henry Schein HSIC Rallies 24 as Shares Approach Key Resistance Level Muzero Acquisition Corp Unit MUZEU Holds Steady at 1003 as SPAC Unit Trades in Tight Range Upexi Inc UPXI Slides 3 as Shares Test Key Support Near 123 Larimar Therapeutics LRMR Edges Higher as Biotech Stock Hovers Near Key Resistance Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers SIGA Q1 2026 Earnings Net Loss of 005 per Share as Revenue Figures Remain Undisclosed Coeptis Therapeutics Warrants COEPW Hold Steady at 001 MicroCap Warrant in Stalemate NTIP Q1 2026 Earnings Net Loss of 002 Reported Stock Dips 067 F Q1 2026 Earnings Massive EPS Beat Drives 922 Stock Surge RFIL Q1 2026 Earnings Strong EPS Beat of 96 Surprises Analysts ReNew Energy Global plc RNW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves APWC Q3 1997 Earnings EPS Misses Estimates by 287 Stock Declines QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress Workday Q1 2026 Earnings EPS Beat Drives Solid Stock Rally